Michael M. Gaba is a Partner in the Washington, D.C. office of Holland & Knight where he is the Federal Policy leader of the firm’s national Health Law and Life Sciences Team. His regulatory and legislative life sciences practice includes counseling and representing medical device and biotech companies before the Food and Drug Administration, the Centers for Medicare and Medicaid Services, and the U.S. Congress. More specifically, Mr. Gaba works on a range of issues related to health care reform with an emphasis on HHS integration, the FDA Amendments Act, post-market surveillance and enforcement, with a particular focus on combination product approval and labeling, as well as coverage, coding, and reimbursement for these sophisticated products.